{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:46:35Z","timestamp":1788389195556,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006084","name":"NIH Office of AIDS Research","doi-asserted-by":"crossref","award":["NIH K01 TW011771-01"],"award-info":[{"award-number":["NIH K01 TW011771-01"]}],"id":[{"id":"10.13039\/100006084","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fogarty International Center and National Institute of Mental Health","award":["D43 TW010543"],"award-info":[{"award-number":["D43 TW010543"]}]},{"name":"Fogarty International Centre of the US National Institutes of Health","award":["2D43TW009744"],"award-info":[{"award-number":["2D43TW009744"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-025-00799-5","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:08:29Z","timestamp":1759154909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The association of antiretroviral therapy type and duration of use with stroke in people living with HIV in Zambia"],"prefix":"10.1186","volume":"22","author":[{"given":"Stanley","family":"Zimba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Ngalamika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mukambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Shankanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taonga","family":"Msimuko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diwell","family":"Mwansa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bwalya","family":"Mulenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Chisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashina","family":"Chomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody","family":"Asukile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Chishimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violet","family":"Kayamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Mulenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Siddiqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masharip","family":"Atadzhanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Saylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"799_CR1","volume-title":"The atlas of heart disease and stroke","author":"J Mackay","year":"2004","unstructured":"Mackay J, Mensah GA. The atlas of heart disease and stroke. Geneva: World Health Organization; 2004."},{"key":"799_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jstrokecerebrovasdis.2004.06.003","volume":"13","author":"J Adamson","year":"2004","unstructured":"Adamson J, Beswick A, Ebrahim S. Is stroke the most common cause of disability? J Stroke Cerebrovasc Dis. 2004;13:171\u20137.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"799_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2377-1-2","volume":"1","author":"GR Williams","year":"2001","unstructured":"Williams GR. Incidence and characteristics of total stroke in the United States. BMC Neurol. 2001;1:1\u20136.","journal-title":"BMC Neurol"},{"key":"799_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/01.STR.0000158917.59233.b7","volume":"36","author":"D Kleindorfer","year":"2005","unstructured":"Kleindorfer D, Panagos P, Pancioli A, et al. Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke. 2005;36:720\u20133.","journal-title":"Stroke"},{"key":"799_CR5","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1136\/bmj.314.7097.1840","volume":"314","author":"CP Warlow","year":"1997","unstructured":"Warlow CP, Dennis M, Jv Gijn, et al. Stroke: a practical guide to management. BMJ-Br Med J-Int. 1997;314:1840.","journal-title":"BMJ-Br Med J-Int"},{"key":"799_CR6","unstructured":"Organization WH. HIV: fact sheet on Sustainable Development Goals (SDGs): health targets: World Health Organization. Regional Office for Europe, 2017."},{"key":"799_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1747-4949.2006.00064.x","volume":"1","author":"AP Kengne","year":"2006","unstructured":"Kengne AP, Anderson CS. The neglected burden of stroke in sub-Saharan Africa. Int J Stroke. 2006;1:180\u201390.","journal-title":"Int J Stroke"},{"key":"799_CR8","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/S0140-6736(16)31460-X","volume":"388","author":"OA Uthman","year":"2016","unstructured":"Uthman OA. Global, regional, and national disability-adjusted life years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132015: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors (GBD) 2015 study. Lancet. 2016;388:1603\u201358.","journal-title":"Lancet"},{"key":"799_CR9","doi-asserted-by":"crossref","unstructured":"Danforth K, Granich R, Wiedeman D, Baxi S, Padian N. Global mortality and morbidity of HIV\/AIDS. 2018.","DOI":"10.1596\/978-1-4648-0524-0_ch2"},{"key":"799_CR10","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1136\/jnnp.2007.116103","volume":"78","author":"B Tipping","year":"2007","unstructured":"Tipping B, de Villiers L, Wainwright H, Candy S, Bryer A. Stroke in patients with human immunodeficiency virus infection. J Neurol Neurosurg Psychiatry. 2007;78:1320\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"799_CR11","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1097\/QAD.0000000000002999","volume":"35","author":"S Zimba","year":"2021","unstructured":"Zimba S, Nutakki A, Chishimba L, et al. Risk factors and outcomes of HIV-associated stroke in Zambia. AIDS. 2021;35:2149\u201355.","journal-title":"AIDS"},{"key":"799_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/QAI.0b013e31825c7f24","volume":"60","author":"FC Chow","year":"2012","unstructured":"Chow FC, Regan S, Feske S, Meigs JB, Grinspoon SK, Triant VA. Comparison of ischemic stroke incidence in HIV-infected and non\u2013HIV-infected patients in a US health care system. JAIDS J Acquir Immune Defic Syndr. 2012;60:351\u20138.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"799_CR13","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S1474-4422(12)70205-3","volume":"11","author":"LA Benjamin","year":"2012","unstructured":"Benjamin LA, Bryer A, Emsley HC, Khoo S, Solomon T, Connor MD. HIV infection and stroke: current perspectives and future directions. Lancet Neurol. 2012;11:878\u201390.","journal-title":"Lancet Neurol"},{"key":"799_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/EDE.0000000000001331","volume":"32","author":"BN Harding","year":"2021","unstructured":"Harding BN, Avoundjian T, Heckbert SR, et al. HIV viremia and risk of stroke among people living with HIV who are using antiretroviral therapy. Epidemiology. 2021;32:457\u201364.","journal-title":"Epidemiology"},{"key":"799_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.122416","volume-title":"Stroke in patients with human immunodeficiency virus infection","author":"M Connor","year":"2007","unstructured":"Connor M. Stroke in patients with human immunodeficiency virus infection. London: BMJ Publishing Group Ltd.; 2007."},{"key":"799_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/infdis\/jix340","volume":"216","author":"LA Benjamin","year":"2017","unstructured":"Benjamin LA, Allain TJ, Mzinganjira H, et al. The role of human immunodeficiency virus\u2013associated vasculopathy in the etiology of stroke. J Infect Dis. 2017;216:545\u201353.","journal-title":"J Infect Dis"},{"key":"799_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/HJR.0b013e328336a150","volume":"17","author":"N Friis-M\u00f8ller","year":"2010","unstructured":"Friis-M\u00f8ller N, Thiebaut R, Reiss P, et al. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil. 2010;17:491\u2013501.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"799_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/cid\/civ296","volume":"61","author":"JR Santos","year":"2015","unstructured":"Santos JR, Saumoy M, Curran A, et al. The lipid-lowering effect of tenofovir\/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial. Clin Infect Dis. 2015;61:403\u20138.","journal-title":"Clin Infect Dis"},{"key":"799_CR19","doi-asserted-by":"crossref","unstructured":"Huhn GD, Shamblaw DJ, Baril J-G, et al. Atherosclerotic cardiovascular disease risk profile of tenofovir alafenamide versus tenofovir disoproxil fumarate. Open forum infectious diseases; 2020: Oxford University Press US: ofz472.","DOI":"10.1093\/ofid\/ofz472"},{"key":"799_CR20","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa062744","volume":"356","author":"Group DS","year":"2007","unstructured":"Group DS. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356:1723\u201335.","journal-title":"N Engl J Med"},{"key":"799_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1212\/WNL.0000000000002278","volume":"86","author":"LA Benjamin","year":"2016","unstructured":"Benjamin LA, Corbett EL, Connor MD, et al. HIV, antiretroviral treatment, hypertension, and stroke in Malawian adults: a case-control study. Neurology. 2016;86:324\u201333.","journal-title":"Neurology"},{"key":"799_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/0049475520953704","volume":"51","author":"S Zimba","year":"2021","unstructured":"Zimba S, Mbewe N, Chishimba L, Chomba M, Saylor D. Immune reconstitution inflammatory syndrome: a report of TB-IRIS after switching from efavirenz to dolutegravir. Trop Doct. 2021;51:216\u20138.","journal-title":"Trop Doct"},{"key":"799_CR23","unstructured":"Walmsley S, Berenguer J, Khuong-Josses M, Kilby J, Lutz T, Podzamczer D. Dolutegravir regimen statistically superior to efavirenz\/tenofovir\/emtricitabine: 96-week results from the SINGLE study (ING114467). Conference on Retrovirues and Opportunistic Infections; 2014."},{"key":"799_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/QAD.0000000000000519","volume":"29","author":"F Raffi","year":"2015","unstructured":"Raffi F, Rachlis A, Brinson C, et al. Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trials. AIDS. 2015;29:167\u201374.","journal-title":"AIDS"},{"key":"799_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-016-0115-x","volume":"13","author":"J Jiang","year":"2016","unstructured":"Jiang J, Xu X, Guo W, et al. Dolutegravir (DTG, S\/GSK1349572) combined with other ARTs is superior to RAL-or EFV-based regimens for treatment of HIV-1 infection: a meta-analysis of randomized controlled trials. AIDS Res Ther. 2016;13:1\u201310.","journal-title":"AIDS Res Ther"},{"key":"799_CR26","first-page":"89","volume":"7","author":"SF Mulenga","year":"2024","unstructured":"Mulenga SF. Population growth as a cause of human development in Zambia. Sustain Dev. 2024;7:89\u2013110.","journal-title":"Sustain Dev"},{"key":"799_CR27","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/hs1001.096191","volume":"32","author":"WJ Jones","year":"2001","unstructured":"Jones WJ, Williams LS, Meschia JF. Validating the questionnaire for verifying stroke-free status (QVSFS) by neurological history and examination. Stroke. 2001;32:2232\u20136.","journal-title":"Stroke"},{"key":"799_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000075794","volume":"17","author":"JF Meschia","year":"2004","unstructured":"Meschia JF, Lojacono MA, Miller MJ, Brott TG, Atkinson EJ, O\u2019Brien PC. Reliability of the questionnaire for verifying stroke-free status. Cerebrovasc Dis. 2004;17:218\u201323.","journal-title":"Cerebrovasc Dis"},{"key":"799_CR29","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1161\/01.STR.25.11.2220","volume":"25","author":"P Lyden","year":"1994","unstructured":"Lyden P, Brott T, Tilley B, et al. Improved reliability of the NIH Stroke Scale using video training NINDS TPA Stroke Study Group. Stroke. 1994;25:2220\u20136.","journal-title":"Stroke"},{"key":"799_CR30","unstructured":"Scale S. Modified Rankin Scale. 2008. http:\/\/www.strokecenter.org\/trials\/scales\/rankin.html."},{"key":"799_CR31","unstructured":"MOH. Zambia Consolidated Guidelines for Treatment and Prevention of HIV Infection. 2022;1\u2013200."},{"key":"799_CR32","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/00004872-200311000-00002","volume":"21","author":"J Whitworth","year":"2003","unstructured":"Whitworth J. World Health Organization, International Society of Hypertension Writing Group. J Hypertens. 2003;21:1983\u201392.","journal-title":"J Hypertens"},{"key":"799_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KGMM Alberti","year":"1998","unstructured":"Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998;15:539\u201353.","journal-title":"Diabet Med"},{"key":"799_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pop.2012.11.003","volume":"40","author":"RH Nelson","year":"2012","unstructured":"Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care. 2012;40:195.","journal-title":"Prim Care"},{"key":"799_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/NT.0000000000000092","volume":"50","author":"FQ Nuttall","year":"2015","unstructured":"Nuttall FQ. Body mass index: obesity, BMI, and health: a critical review. Nutr Today. 2015;50:117\u201328.","journal-title":"Nutr Today"},{"key":"799_CR36","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/0140-6736(91)93206-O","volume":"337","author":"J Bamford","year":"1991","unstructured":"Bamford J, Sandercock P, Dennis M, Warlow C, Burn J. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521\u20136.","journal-title":"Lancet"},{"key":"799_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"key":"799_CR38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"799_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-021-00383-7","volume":"18","author":"K Dorjee","year":"2021","unstructured":"Dorjee K, Desai M, Choden T, Baxi SM, Hubbard AE, Reingold AL. Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States. AIDS Res Ther. 2021;18:1\u201310.","journal-title":"AIDS Res Ther"},{"key":"799_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.292.2.191","volume":"292","author":"JE Gallant","year":"2004","unstructured":"Gallant JE, Staszewski S, Pozniak AL, et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004;292:191\u2013201.","journal-title":"JAMA"},{"key":"799_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-025-04833-2","volume":"25","author":"M Nweke","year":"2025","unstructured":"Nweke M, Mshunqane N. Characterization and stratification of risk factors of stroke in people living with HIV: a theory-informed systematic review. BMC Cardiovasc Disord. 2025;25:1\u201334.","journal-title":"BMC Cardiovasc Disord"},{"key":"799_CR42","unstructured":"Wijting I, Rokx C, Wit F, Postma A, Hoepelman A, van der Ende M. Integrase Inhibitors are an Independent Risk Factor for IRIS: an ATHENA-Cohort Study. Conference on Retroviruses and Opportunistic Infections. 2017; 13\u201316."},{"key":"799_CR43","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.2174\/1381612823666170329142059","volume":"23","author":"M Psichogiou","year":"2017","unstructured":"Psichogiou M, Poulakou G, Basoulis D, Paraskevis D, Markogiannakis A, L. Daikos G. Recent advances in antiretroviral agents: potent integrase inhibitors. Curr Pharm Design. 2017;23:2552\u201367.","journal-title":"Curr Pharm Design"},{"key":"799_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/v16091462","volume":"16","author":"CG Roux","year":"2024","unstructured":"Roux CG, Mason S, du Toit LD, Nel J-G, Rossouw TM, Steel HC. Comparative effects of efavirenz and dolutegravir on metabolomic and inflammatory profiles, and platelet activation of people living with HIV: a pilot study. Viruses. 2024;16:1462.","journal-title":"Viruses"},{"key":"799_CR45","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1016\/S2352-3018(23)00328-4","volume":"11","author":"DM Byonanebye","year":"2024","unstructured":"Byonanebye DM, Polizzotto MN, Maltez F, et al. Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts. Lancet HIV. 2024;11:e321\u201332.","journal-title":"Lancet HIV"},{"key":"799_CR46","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/0956462417732226","volume":"29","author":"J Echecopar-Sabogal","year":"2018","unstructured":"Echecopar-Sabogal J, D\u2019Angelo-Piaggio L, Chanam\u00e9-Baca DM, Ugarte-Gil C. Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and\/or metabolic syndrome in HIV-infected patients: a systematic review and meta-analysis. Int J STD AIDS. 2018;29:443\u201352.","journal-title":"Int J STD AIDS"},{"key":"799_CR47","doi-asserted-by":"crossref","unstructured":"Parra-Rodriguez L, Sahrmann JM, Butler AM, Olsen MA, Powderly WG, O\u2019Halloran JA. Antiretroviral Therapy and Cardiovascular Risk in People With HIV in the United States\u2014An Updated Analysis. Open Forum Infectious Diseases. Oxford University Press US. 2024; ofae485","DOI":"10.1093\/ofid\/ofae485"},{"key":"799_CR48","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1212\/WNL.0000000000201388","volume":"100","author":"A Smyth","year":"2023","unstructured":"Smyth A, O\u2019Donnell M, Rangarajan S, et al. Alcohol intake as a risk factor for acute stroke: the INTERSTROKE study. Neurology. 2023;100:e142\u201353.","journal-title":"Neurology"},{"key":"799_CR49","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/jama.289.5.579","volume":"289","author":"K Reynolds","year":"2003","unstructured":"Reynolds K, Lewis B, Nolen JDL, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289:579\u201388.","journal-title":"JAMA"},{"key":"799_CR50","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ijcard.2014.04.225","volume":"174","author":"C Zhang","year":"2014","unstructured":"Zhang C, Qin Y-Y, Chen Q, et al. Alcohol intake and risk of stroke: a dose\u2013response meta-analysis of prospective studies. Int J Cardiol. 2014;174:669\u201377.","journal-title":"Int J Cardiol"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00799-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-025-00799-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00799-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:03:48Z","timestamp":1759158228000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00799-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["799"],"URL":"https:\/\/doi.org\/10.1186\/s12981-025-00799-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6945551\/v1","asserted-by":"object"}]},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"21 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}